Curcumin review found smaller lung tumors in mice
Animal experiments and analyses of possible biological targets offer preliminary research leads, without establishing treatment or prevention benefits in people.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The pooled animal experiments found smaller tumor volumes with curcumin than with control conditions. This supports further investigation in experimental lung cancer models, but it does not establish that curcumin treats or prevents lung cancer in humans. The accompanying analyses suggest possible biological targets without demonstrating a clinical benefit from acting on them.
The efficacy evidence comes from animals. The abstract provides no pooled tumor-volume effect size, treatment duration or dosing details, limiting interpretation of the size and consistency of the experimental result.
What researchers found
Tumor volume in mice
Lower with curcumin than control in the meta-analysis; treatment duration and pooled effect size were not reported.
What the experiments measured
The central experimental outcome was tumor volume in mice with non-small-cell lung cancer. A statistically significant result indicates evidence of a difference, but the abstract does not quantify how large that difference was.
What the target analyses add
Computer-based analyses identified candidate targets and predicted interactions with curcumin. A separate genetic analysis implicated AURKB in cancer risk, but that finding does not demonstrate that curcumin changes this target sufficiently to benefit patients.
The original publication
Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta-Analysis, Network Pharmacology, and Mendelian Randomization.
Guo Y, Xu H, Shen P et al.
Phytother Res · 2025
- PubMed ID
- 40925573
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.